Methyldopa

Methyldopa, antihypertensive drug, α Receptor agonists are commonly used in tablets. This product is a kind of stimulant for vascular motor center α- Receptors, thus inhibiting the external sensory nerve, producing a hypotensive effect, accompanied by slowing down the heart rate, reducing the cardiac output, dilating the arterioles, significantly reducing the resistance of peripheral blood vessels, and not significantly reducing the cardiac output during long-term application.

Product Overview

Methyldopa is a centrally acting antihypertensive agent that functions as an α₂-adrenergic receptor agonist. It is primarily used to manage hypertension during pregnancy and in patients with renal impairment. This document outlines its physicochemical properties, pharmacological effects, and regulatory compliance.

Basic Physicochemical Properties

Pharmacological Profile

Therapeutic Applications & Dosage

Pharmacopoeial Compliance

Stability & Storage Conditions

Conclusion

Methyldopa remains a safe and effective antihypertensive, particularly in pregnancy and renal impairment. Its unique CNS-mediated mechanism and established safety profile make it a preferred choice in specific patient populations.

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

Declaration: The products displayed on this website are intended exclusively for industrial applications or scientific research. They are not intended for medical, pharmaceutical, or food use. In accordance with applicable laws and regulations, purchasing organizations must hold valid qualifications and approvals.